Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) — Strategic Asset Allocation Index
Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) has a Strategic Asset Allocation Index of 32.0% as of September 2023. Strategic assets (PP&E of CN¥2.43 Billion plus long-term investments of CN¥-) total CN¥2.43 Billion, measured against net assets of CN¥7.60 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 002773 net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Chengdu Kanghong Pharmaceuticals Group Co Ltd Strategic Asset Allocation Index (2011–2021)
This chart shows how Chengdu Kanghong Pharmaceuticals Group Co Ltd's Strategic Asset Allocation Index has evolved across 11 annual periods from 2011 to 2021. As of September 2023, the index stands at 32.0%, representing strategic assets of CN¥2.43 Billion against net assets of CN¥7.60 Billion CNY. For live market cap and overall valuation, see Chengdu Kanghong Pharmaceuticals Group C market capitalisation.
Annual Strategic Asset Allocation Index for Chengdu Kanghong Pharmaceuticals Group Co Ltd (2011–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Chengdu Kanghong Pharmaceuticals Group Co Ltd from 2011 to 2021, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See 002773 net asset value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 34.4% | CN¥2.10 Billion | CN¥2.10 Billion | CN¥- | CN¥6.10 Billion | ▲ +3.4 pp |
| 2020 | 30.9% | CN¥1.78 Billion | CN¥1.78 Billion | CN¥- | CN¥5.76 Billion | ▲ +3.4 pp |
| 2019 | 27.6% | CN¥1.27 Billion | CN¥1.27 Billion | CN¥- | CN¥4.62 Billion | ▲ +6.8 pp |
| 2018 | 20.8% | CN¥849.08 Million | CN¥839.58 Million | CN¥9.50 Million | CN¥4.08 Billion | ▲ +2.0 pp |
| 2017 | 18.8% | CN¥664.75 Million | CN¥664.75 Million | CN¥- | CN¥3.54 Billion | ▲ +0.3 pp |
| 2016 | 18.5% | CN¥537.59 Million | CN¥537.59 Million | CN¥- | CN¥2.90 Billion | ▼ -1.3 pp |
| 2015 | 19.8% | CN¥500.78 Million | CN¥500.78 Million | CN¥- | CN¥2.52 Billion | ▼ -10.4 pp |
| 2014 | 30.2% | CN¥487.11 Million | CN¥487.11 Million | CN¥- | CN¥1.61 Billion | ▼ -5.6 pp |
| 2013 | 35.8% | CN¥498.04 Million | CN¥498.04 Million | CN¥- | CN¥1.39 Billion | ▼ -11.6 pp |
| 2012 | 47.5% | CN¥524.95 Million | CN¥524.95 Million | CN¥- | CN¥1.11 Billion | ▼ -4.5 pp |
| 2011 | 51.9% | CN¥486.33 Million | CN¥486.33 Million | CN¥- | CN¥936.39 Million | — |